ctrl K

Price Alert

Design Therapeutics Inc. (DSGN)

NASDAQ: DSGN · Real-Time Price · USD

5.35

0.19 (3.68%)

At close: Aug 15, 2025, 3:59 PM

5.33

-0.37%

After-hours: Aug 15, 2025, 04:04 PM EDT

Design Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	22.56M	21.2M	26.5M	298.57M
Short-Term Investments	222.91M	260.6M	303.89M	85.5M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	427K	430K	459K	n/a
Receivables	1.26M	1.43M	1.11M	110K
Inventory	n/a	n/a	n/a	1.25M
Other Current Assets	n/a	n/a	n/a	-1.25M
Total Current Assets	248.04M	284.58M	335.12M	385.44M
Property-Plant & Equipment	3.63M	4.63M	5.56M	5.12M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.05M	5.06M	6.02M	5.12M
Total Assets	252.09M	289.64M	341.14M	390.56M
Account Payables	2.19M	1.94M	3.02M	1.62M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	800K	716K	640K	489K
Other Current Liabilities	-800K	2.22M	2.93M	533K
Total Current Liabilities	8.46M	9.62M	10.78M	5.28M
Long-Term Debt	n/a	2.33M	3.05M	3.14M
Other Long-Term Liabilities	n/a	-2.33M	-3.05M	-3.14M
Total Long-Term Liabilities	1.53M	2.33M	3.05M	3.14M
Total Liabilities	10M	11.96M	13.83M	8.43M
Total Debt	2.33M	3.05M	3.69M	3.63M
Common Stock	6K	6K	6K	6K
Retained Earnings	-227.21M	-177.63M	-110.76M	-47.46M
Comprehensive Income	475K	62K	-3.36M	-244K
Shareholders Equity	242.1M	277.69M	327.31M	382.13M
Total Investments	222.91M	260.6M	303.89M	85.5M